The U.S. Department of Justice files another brief in the Sherley v. Sebelius case over NIH funding of embryonic stem cell research.
The Coalition for the Advancement of Medical Research files an amicus brief in support of the Department of Justice's position on the the Sherley v. Sebelius lawsuit over NIH funding for embryonic stem cell research.
The judicial injunction blocking federally funded human embryonic stem cell research not only blocks potential life-saving research but also threatens to undermine the system of peer-reviewed science that has helped make America the unquestioned world leader in scientific discovery.
With today’s announcement of NIH’s new Guidelines for Human Stem Cell Research, President Obama’s welcome changes in our national policy on embryonic stem cell research are now a reality.
Dear Sir or Madam: The Association of American Universities (AAU) comprises 60 leading U.S. research universities which together perform approximately 60 percent of the extramural research funded by the National Institutes of Health (NIH). I write to offer AAU’s views on the Draft National Institutes of Health Guidelines for Human Stem Cell Research of April 23, 2009.
On behalf of research universities across America, I want to thank President Obama for his executive order on embryonic stem cell research. This order allows America’s medical scientists to do their jobs: pursue scientific inquiry in one of the most promising research areas of our time. Our nation is now able to support this extraordinary basic research, which will not only lead to cures for ailments that afflict millions of people here and around the world but also change fundamentally the way we understand and treat human diseases.
Dear Leader Frist: As president of the Association of American Universities (AAU), representing 60 leading public and private research universities in the Unites States, I am writing to thank you for your efforts in introducing H.R. 810, the Stem Cell Research Enhancement Act, to the Senate next week.
Dear Leader Frist: On behalf of the Association of American Universities, which represents 60 leading public and private research universities in the United States, I am writing to urge you to vote “yes” on H.R. 810, the Stem Cell Research Enhancement Act. This legislation would broaden the current federal policy on human embryonic stem cell research to authorize federally funded research on cell lines derived from embryos developed for in-vitro fertilization (IVF) that otherwise would be discarded.
The nation’s research universities applaud House passage today of H.R. 810, the Stem Cell Research Enhancement Act, introduced by Representatives Castle and DeGette. It is our hope that the Senate will act soon on H.R. 810 as well. It is also our hope that if this bill comes to President Bush for his signature, he will consider allowing it to become law.
Dear Representative: As presidents and chancellors of the leading public and private research universities of the Association of American Universities (AAU), we urge you to vote in favor of H.R. 810, the Stem Cell Research Enhancement Act of 2005, as introduced by Representatives Michael Castle and Diana DeGette. This legislation will broaden the current federal policy on embryonic stem cell research to authorize federally funded research on cell lines created from embryos developed for in-vitro fertilization (IVF) that otherwise would be discarded.
The House Republican leadership recently agreed to hold a debate and vote sometime in the next several weeks on expanding the current federal policy on embryonic stem cell research. In anticipation of this vote, the Coalition for the Advancement of Medical Research (CAMR, the stem cell coalition, of which AAU is a member) is reaching out to Members of Congress to urge their support for HR 810, the Castle- DeGette bill which would expand the policy for federal funding of embryonic stem cell research. Following are some talking points to consider when talking with your state delegation about this issue:
Dear Mr. President: We write to urge you to expand the current federal policy concerning embryonic stem cell research.
November 19, 2003 Dear Senator: I write on behalf of the member universities of the Association of American Universities to express our concern about a provision in the omnibus appropriations bill authored by Rep. Weldon of Florida that would prohibit the Patent and Trademark Office from issuing “patents on claims dire
Dear Representative Greenwood: The Association of American Universities, which represents 62 leading public and private research universities, strongly supports H.R. 801, the Cloning Prohibition Act of 2003. Along with Representatives Peter Deutsch (D-FL), Anna Eshoo (D-CA), Diana DeGette (D-CO), and Mark Kirk (R-IL), your leadership in protecting research using nuclear transplantation to produce stem cells is greatly appreciated.
Dear Secretary Thompson: On behalf of the Board of Directors of the Coalition for the Advancement of Medical Research (CAMR), I write to follow up on our August 10 meeting with you when we discussed the President's stem cell research policy. We reiterate our sincere appreciation for your continued support of the need for federal funding of embryonic stem cell research.
Dear President Bush: Attached is a letter that our three associations, joined by 112 college and university presidents and chancellors, have written to Secretary Thompson. The letter urges him to permit the current National Institutes of Health guidelines governing stem cell research to remain in effect, since he is conducting the review of this research that you have requested.
Dear Mr. President and Secretary Thompson: Stem cell research is the wave of the future in biomedical research. As you know, there are three sources of stem cells - adult, fetal tissue and embryo. The National Institute of Health recently issued explicit guidelines for research involving stem cells derived from embryos and/or fetal tissue. They provide stringent requirements which enable scientists to conduct stem cell research within the constraints of careful federal oversight and standards.
To the Honorable George W. Bush, President of the United States We the undersigned urge you to support Federal funding for research using human pluripotent stem cells. We join with other research institutions and patient groups in our belief that the current National Institutes of Health (NIH) guidelines, which enable scientists to conduct stem cell research within the rigorous constraints of federal oversight and standards, should be permitted to remain in effect. The discovery of human pluripotent stem cells is a significant milestone in medical research. Federal support for the enormous creativity of the US biomedical community is essential to translate this discovery into novel therapies for a range of serious and currently intractable diseases.
Dear Senator Specter: We believe in possibilities and the power of medical research to make them happen. As you know, on April 26th, Christopher Reeve will testify before Congress on a matter that is beyond a personal passion, on a matter upon which his entire future may rely - the vision and promise of stem cell research. Stem cell research has the potential to improve the lives of millions of Americans. Thus, we join our voices with that of Christopher Reeve in saying to the United States Congress, stem cell research must be supported by the federal government with the appropriate public scrutiny by the National Institutes of Health. The lives of countless Americans who suffer from a variety of devastating illnesses may depend upon it.
View more articles about this topic in our archives
1200 New York Ave, NW, Suite 550 | Washington, DC 20005Phone: 202.408.7500 | Fax: 202.408.8184
Home | About AAU | University Research & Graduate Education | News Room | Budget & Appropriations
Policy Issues | AAU Publications | Members Services | Sitemap | RSS Feeds | Contact | All Content © AAU 2016